Evidence map›Paper›PMID 26811472›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation.

Allison Craney, Aileen Kelly, Luying Jia, Indro Fedrigo, Hongtao Yu, Michael Rape

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. TEAD Inhibitors Sensitize KRASPharmaceuticals (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Zombies Never Die: The Double Life Bub1 Lives in Mitosis.Frontiers in cell and developmental biology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. UBE2S Learns Self-Control.Structure (London, England : 1993) · 2019
    Article
  12. Review
  13. Review
  14. Protein phosphatases in the regulation of mitosis.The Journal of cell biology · 2019
    Review
  15. Review
  16. Review
  17. Enzymatic Logic of Ubiquitin Chain Assembly.Frontiers in physiology · 2019
    Review
  18. Kinase and Phosphatase Cross-Talk at the Kinetochore.Frontiers in cell and developmental biology · 2018
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Allison CraneyDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720;
Aileen KellyDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720;
Luying JiaDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Indro FedrigoDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720;
Hongtao YuDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Michael RapeDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; Howard Hughes Medical Institute, University of California, Berkeley, CA 94720 mrape@berkeley.edu.
Howard Hughes Medical Institute · USUniversity of California, Berkeley · US

Funding

Genome Sequencer FLXS10RR029668 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI NGAI, JOHN J. · 2010 to 2010
$623k
Illumina Sequencer to Facilitate Functional Genomics at BerkeleyS10RR027303 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI TAYLOR, JOHN W. · 2010 to 2010
$500k
LTQ XL Linear Quadrupole Ion Trap Mass SpectrometerS10RR025622 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI KOHLSTAEDT, LORI · 2009 to 2009
$463k
Howard Hughes Medical InstituteNCRR NIH HHS S10 RR025622NCRR NIH HHS S10RR025622NCRR NIH HHS S10 RR027303NCRR NIH HHS S10RR027303NCRR NIH HHS S10 RR029668NCRR NIH HHS S10RR029668
6 · The paper itself

Abstract

Most metazoan E3 ligases contain a signature RING domain that promotes the transfer of ubiquitin from the active site of E2 conjugating enzymes to lysine residues in substrates. Although these RING-E3s depend on E2 enzymes for catalysis, how they turn on their E2s at the right time and place remains poorly understood. Here we report a phosphorylation-dependent mechanism that ensures timely activation of the E2 Ube2S by its RING-E3, the anaphase-promoting complex (APC/C); while phosphorylation of a specific serine residue in the APC/C coactivator Cdc20 prevents delivery of Ube2S to the APC/C, removal of this mark by PP2A(B56) allows Ube2S to bind the APC/C and catalyze ubiquitin chain elongation. PP2A(B56) also stabilizes kinetochore-microtubule attachments to shut off the spindle checkpoint, suggesting that cells regulate the E2-E3 interplay to coordinate ubiquitination with critical events during cell division.

Indexed as

Anaphase-Promoting Complex-CyclosomeBiocatalysisCdc20 ProteinsHeLa CellsHumansKinetochoresPhosphorylationProtein BindingProtein Phosphatase 2SerineUbiquitinAnaphase-Promoting Complex-CyclosomeCdc20 ProteinsProtein Phosphatase 2SerineUbiquitinanaphase-promoting complexAPC/CphosphorylationUbe2Subiquitin

Identifiers

PMID26811472
PMCPMC4760819
OpenAlexW2260165777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.